Retraction
Evaluation of Tresiba Combined with Six Ingredient Rehmannia Pill in the Treatment of Type 2 Diabetes
Paper Information
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Informed/Patient Consent - None/Withdrawn
- Investigation by Journal/Publisher
- Investigation by Third Party
- Lack of IRB/IACUC Approval and/or Compliance
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9875409Citations (4)
4
Total Citations1
Post-Retraction(25.0%)
2
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
153
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Inflammation-Targeted Drug Delivery Strategies via Albumin-Based Systems
Bangqing Wu, Jingwen Wang, Yi Chen et al. (4 authors)
ACS Biomaterials Science & Engineering
Published: Jan 2024
6 citations
6 citations
153 days after retraction
Research progress on albumin-based hydrogels: Properties, preparation methods, types and its application for antitumor-drug delivery and tissue engineering
Run Meng, Huimin Zhu, Peiying Deng et al. (8 authors)
Frontiers in Bioengineering and Biotechnology
Open Access
Published: Apr 2023
14 citations
14 citations
120 days before retraction
Retracted: Evaluation of Tresiba Combined with Six Ingredient Rehmannia Pill in the Treatment of Type 2 Diabetes
Journal of Healthcare Engineering
Journal of Healthcare Engineering
Open Access
Published: Jan 2023
220 days before retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
2.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025